SURMODICS INC — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-06-06

Reporting Person: Phillips Bryan K (SVP, Gen Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-06	Common Stock	S	13788	$51.6235	Disposed	28099	Direct
2018-06-06	Common Stock	S	1212	$52.8122	Disposed	26887	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Reflects the weighted average price of 13,788 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $51.25 to $52.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 1,212 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $52.45 to $53.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.